18F-DOPA PET-guided proton beam therapy improved overall survival in older glioblastoma patients, with a median OS of 13.1 months and no grade 4 adverse events. The hypofractionated regimen, completed ...

Corticosteroids may cut short-term mortality in patients with severe pneumonia or acute respiratory distress syndrome (ARDS), but evidence backing a long-term mortality benefit remains murky, ...